Morning Briefing
Summaries of health policy coverage from major news organizations
New Cancer Drug Renews Debate About Costs
The drug Opdivo, which went on sale in Japan this week, costs an average of $143,000 per patient, The Wall Street Journal reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
